{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:28:53Z","timestamp":1715646533745},"reference-count":36,"publisher":"Pharmaceutical Society of Japan","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological &amp; Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2024,3,20]]},"DOI":"10.1248\/bpb.b23-00808","type":"journal-article","created":{"date-parts":[[2024,3,19]],"date-time":"2024-03-19T22:11:50Z","timestamp":1710886310000},"page":"660-668","source":"Crossref","is-referenced-by-count":0,"title":["Spasmolytic Effect of Flopropione Does Not Involve Catechol-&lt;i&gt;O&lt;\/i&gt;- methyltransferase (COMT) Inhibition"],"prefix":"10.1248","volume":"47","author":[{"given":"Yoko","family":"Amagase","sequence":"first","affiliation":[{"name":"Department of Pathophysiology, Faculty of Pharmaceutical Sciences, Doshisha Women\u2019s College of Liberal Arts"},{"name":"Faculty of Pharmacy, Osaka Medical and Pharmaceutical University"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mari","family":"Hoshiyama","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Faculty of Pharmaceutical Sciences, Doshisha Women\u2019s College of Liberal Arts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiho","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Faculty of Pharmaceutical Sciences, Doshisha Women\u2019s College of Liberal Arts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miwa","family":"Kanbara","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Faculty of Pharmaceutical Sciences, Doshisha Women\u2019s College of Liberal Arts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumiko","family":"Mizukawa","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Faculty of Pharmaceutical Sciences, Doshisha Women\u2019s College of Liberal Arts"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuro","family":"Urushidani","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Faculty of Pharmaceutical Sciences, Doshisha Women\u2019s College of Liberal Arts"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"163","reference":[{"key":"1","unstructured":"1) Package insert of Cospanon Tablets. https:\/\/www.info.pmda.go.jp\/go\/pack\/1249007F1032_1_09\/."},{"key":"2","unstructured":"2) Interview form of Cospanon. http:\/\/qws-data.qlife.jp\/meds\/interview\/1249007F1032."},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Hollingsworth JM, Canales BK, Rogers MAM, Sukumar S, Yan P, Kuntz GM, Dahm P. Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis. <i>BMJ<\/i>, <b>355<\/b>, i6112 (2016).","DOI":"10.1136\/bmj.i6112"},{"key":"4","unstructured":"4) <i>Goodman &amp; Gilman\u2019s The Pharmacological Basis of Therapeutics<\/i>, 14th Ed. (Brunton LL, Knollmann BC eds.) Chapter 10: Neurotransmission:, Chapter 13: Neuromuscular junction and autonomic ganglia; nicotine, muscle relaxants, and spasmolytics: Hibbs RE, Zambon AC. Chapter 54: Gastrointestinal motility and water flux, emesis, and biliary and pancreatic disease: Sharkey KA, MacNaughton WK (2023)."},{"key":"5","unstructured":"5) Katzung BG, Vanderah TW. <i>Basic &amp; Clinical Pharmacology<\/i> 15th Ed., Chapter 9: Biaggioni I. Adrenoceptor agonists &amp; sympathetic drugs: Chapter 28: Aminoff MJ. Pharmacologic management of Parkinsonism &amp; other movement disorders, McGraw-Hill, NY (2021)."},{"key":"6","unstructured":"6) Ritter JM, Flower R, Henderson G, Loke YK, MacEwan D, Robinson E, Fullerton J. <i>Rang &amp; Dale\u2019s Pharmacology 10th Ed<\/i>. Chapter 16: 5-Hydroxytryptamine and the purines. Chapter 30: The gastrointestinal tract. Elsevier, Amsterdam (2023)."},{"key":"7","unstructured":"7) Barrett KE, Barman SM, Brooks HL. <i>Ganong&apos;s Review of Medical Physiology<\/i>, 26th Ed. Chapter 7: Neurotransmitters &amp; neuromodulators. Chapter 28: Transport &amp; metabolic functions of the liver. Mcgraw-Hill, NY (2019)."},{"key":"8","unstructured":"8) Hall JE, Hall ME. <i>Guyton Hall Textbook of Medical Physiology<\/i>. 14th Ed. Chapter 65: Secretory functions of the alimentary tract. Elsevier, Amsterdam (2020)."},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Boulton AA, Eisenhofer G. Catecholamine metabolism: from molecular understanding to clinical diagnosis and treatment. <i>Catecholamines: Bridging basic science with clinical medicine<\/i>. (Goldstein DS, Eisenhofer G, McCarty R, eds.) Academic Press, New York, pp. 273\u2013292 (1997).","DOI":"10.1016\/S1054-3589(08)60746-2"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Jordan J, Lipp A, Tank J, Schr\u00f6der C, Stoffels M, Franke G, Diedrich A, Arnold G, Goldstein DS, Sharma AM, Luft FC. Catechol-O-methyltransferase and blood pressure in humans. <i>Circulation<\/i>, <b>106<\/b>, 460\u2013465 (2002).","DOI":"10.1161\/01.CIR.0000022844.50161.3B"},{"key":"11","unstructured":"11) Illi A, Sundberg S, Koulu M, Scheinin S, Hein\u00e4vaara S, Gordin A. COMT inhibition by high-dose entacapone does not affect hemodynamics but changes catecholamine metabolism in healthy volunteers at rest and during exercise. <i>Int. J. Clin. Pharmacol. Ther.<\/i>, <b>32<\/b>, 582\u2013588 (1994)."},{"key":"12","unstructured":"12) Package insert of Comtan Tablets. https:\/\/www.info.pmda.go.jp\/go\/pack\/1169014F1021_1_13\/."},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Satoh H, Inada I, Maki Y. Role of an intracellular Ca store in trepibutone (AA-149)-induced relaxation of the depolarized smooth muscle of the guinea pig taenia coli. <i>Jpn. J. Pharmacol.<\/i>, <b>31<\/b>, 593\u2013599 (1981).","DOI":"10.1254\/jjp.31.593"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Kanda Y. Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. <i>Bone Marrow Transplant.<\/i>, <b>48<\/b>, 452\u2013458 (2013).","DOI":"10.1038\/bmt.2012.244"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Hattori K, Matsuura M, Fujiwara M, Shimamoto K. Inhibition of catechol-O-methyltransferase by hydroxybenzenes and related compounds. <i>Jpn. J. Pharmacol.<\/i>, <b>19<\/b>, 282\u2013286 (1969).","DOI":"10.1254\/jjp.19.282"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Nissinen E, Linden I-B, Schultz E, Pohto P. Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone. <i>Naunyn Schmiedebergs Arch. Pharmacol.<\/i>, <b>346<\/b>, 262\u2013266 (1992).","DOI":"10.1007\/BF00173538"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Ichikawa S, Yaegashi T. Effects of 2,4,6-trihydroxypropiophenone on the motility of bile duct and ureter. <i>Nihon Heikatsukin Gakkai Zasshi<\/i>, <b>4<\/b>, 151\u2013159 (1968).","DOI":"10.1540\/jsmr1965.4.151"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Kannan MS, Prakash YS, Brenner T, Mickelson JR, Sieck GC. Role of ryanodine receptor channels in Ca<sup>2+<\/sup> oscillations of porcine tracheal smooth muscle. <i>Am. J. Physiol. Lung Cell. Mol. Physiol.<\/i>, <b>272<\/b>, L659\u2013L664 (1997).","DOI":"10.1152\/ajplung.1997.272.4.L659"},{"key":"19","unstructured":"19) Zorzato F, Scutari E, Tegazzin V, Clementi E, Treves S. Chlorocresol: an activator of ryanodine receptor-mediated Ca<sup>2+<\/sup> release. <i>Mol. Pharmacol.<\/i>, <b>44<\/b>, 1192\u20131201 (1993)."},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Gambardella J, Morelli MB, Wang X, Castellanos V, Mone P, Santulli G. The discovery and development of IP<sub>3<\/sub> receptor modulators: An update. <i>Expert Opin. Drug Discov.<\/i>, <b>16<\/b>, 709\u2013718 (2021).","DOI":"10.1080\/17460441.2021.1858792"},{"key":"21","unstructured":"21) Cahen R. Phloroglucinol: a pharmacological reevaluation\u2014smooth muscle relaxing properties. <i>Arch.int. Pharmacodyn. Ther.<\/i>, <b>138<\/b>, 311\u2013319 (1962)."},{"key":"22","unstructured":"22) Cahen R, Boucherle A. Etude pharmacologique de la trihydroxy 2,4,6-propiophenone. <i>C. R. Seances Soc. Biol. Fil.<\/i>, <b>157<\/b>, 112\u2013116 (1963)."},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Johnson ES. The spasmolytic actions of pyrogallol and catechol on the isolated guinea-pig ileum. <i>J. Pharm. Pharmacol.<\/i>, <b>14<\/b>, 272\u2013279 (1962).","DOI":"10.1111\/j.2042-7158.1962.tb11093.x"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Palma PN, Kiss LE, Soares-Da-Silva P. Catechol-O-methyl-transferase inhibitors: Present problems and relevance of the new ones RSC drug. <i>Discovery Series Emerging Drugs and Targets for Parkinson\u2019s Disease<\/i>. Ed. (Martinez A, Gil C eds.) No. 34, Royal Society of Chemistry Publishing, London, pp. 83\u2013109 (2013).","DOI":"10.1039\/9781849737357-00083"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Inoue S. Effects of 1,3,5-Trihydroxybenzene and 2,4,6-trihydroxy-1-propiophenone on the smooth muscle organs. <i>Jpn. J. Pharmacol.<\/i>, <b>19<\/b>, 224\u2013233 (1969).","DOI":"10.1254\/jjp.19.224"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Gi\u0307dener S, Gumustekin M, Kirkali Z. Pharmacological analysis of 5-hydroxytryptamine effects on human isolated ureter. <i>Pharmacol. Res.<\/i>, <b>39<\/b>, 487\u2013491 (1999).","DOI":"10.1006\/phrs.1999.0469"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Hauser DS, Mevissen M, Weiss R, Portier CJ, Scholtysik G, Studer UE, Danuser H. Effects of ketanserin and DOI on spontaneous and 5-HT-evoked peristalsis of the pig ureter <i>in vivo<\/i>. <i>Br. J. Pharmacol.<\/i>, <b>135<\/b>, 1026\u20131032 (2002).","DOI":"10.1038\/sj.bjp.0704536"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Dodel RC, Hafner D, Borchard U. Characterization of histamine receptors in the ureter of the dog. <i>Eur. J. Pharmacol.<\/i>, <b>318<\/b>, 395\u2013402 (1996).","DOI":"10.1016\/S0014-2999(96)00765-0"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Messori E, Rizzi CA, Candura SM, Lucchelli A, Balestra B, Tonini M. 5-Hydroxytryptamine receptors that facilitate excitatory neuromuscular transmission in the guinea-pig isolated detrusor muscle. <i>Br. J. Pharmacol.<\/i>, <b>115<\/b>, 677\u2013683 (1995).","DOI":"10.1111\/j.1476-5381.1995.tb14986.x"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Putney JW, Bird GS. Cytoplasmic calcium oscillations and store-operated calcium influx. <i>J. Physiol.<\/i>, <b>586<\/b>, 3055\u20133059 (2008).","DOI":"10.1113\/jphysiol.2008.153221"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Boittin FX, Macrez N, Halet G, Mironneau J. Norepinephrine-induced Ca<sup>2+<\/sup> waves depend on InsP<sub>3<\/sub> and ryanodine receptor activation in vascular myocytes. <i>Am. J. Physiol. Cell Physiol.<\/i>, <b>277<\/b>, C139\u2013C151 (1999).","DOI":"10.1152\/ajpcell.1999.277.1.C139"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) McGeown JG. Interactions between inositol 1,4,5-trisphosphate receptors and ryanodine receptors in smooth muscle: one store or two? <i>Cell Calcium<\/i>, <b>35<\/b>, 613\u2013619 (2004).","DOI":"10.1016\/j.ceca.2004.01.016"},{"key":"33","unstructured":"33) Cayman Chemical Product Information. https:\/\/cdn.caymanchem.com\/cdn\/insert\/64970.pdf."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Gardner AL, Choo LK, Mitchelson F. Comparison of the effects of some muscarinic agonists on smooth muscle function and phosphatidylinositol turnover in the guinea pig taenia caeci. <i>Br. J. Pharmacol.<\/i>, <b>94<\/b>, 199\u2013211 (1988).","DOI":"10.1111\/j.1476-5381.1988.tb11516.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Politi A, Gaspers LD, Thomas AP, H\u00f6fer T. Models of IP<sub>3<\/sub> and Ca<sup>2+<\/sup> oscillations: frequency encoding and identification of underlying feedbacks. <i>Biophys. J.<\/i>, <b>90<\/b>, 3120\u20133133 (2006).","DOI":"10.1529\/biophysj.105.072249"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Li G, Wollheim CB, Pralong W-F. Oscillations of cytosolic free calcium in bombesin-stimulated HIT-T15 cells. <i>Cell Calcium<\/i>, <b>19<\/b>, 535\u2013546 (1996).","DOI":"10.1016\/S0143-4160(96)90063-9"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/3\/47_b23-00808\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T04:56:50Z","timestamp":1715576210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/3\/47_b23-00808\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,20]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b23-00808","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,20]]},"article-number":"b23-00808"}}